Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing

NIH RePORTER · NIH · R44 · $750,000 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10012386
Project number
4R44HL149566-02
Recipient
CURI BIO INC
Principal Investigator
Nicholas Andrew Geisse
Activity code
R44
Funding institute
NIH
Fiscal year
2020
Award amount
$750,000
Award type
4N
Project period
2019-09-01 → 2022-05-31